Skip to main content
. 2023 Jun 20;9(2):45–52. doi: 10.1016/j.afos.2023.06.001

Table 6.

Indications for bone mineral density measurement by DXA scan.

Women ≥ 65 years and men ≥ 70 years
Early menopause (before 45 years), including surgical menopause
A history of hypoestrogenism ≥ 1 year before menopause, excluding pregnancy and lactation
  • -

    Receiving GnRH agonist

  • -

    Functional hypothalamic amenorrhea, eg, medical condition, excessive exercise, anorexia nervosa

Women <65 years and men <70 years with a risk factor for osteoporotic fracture
  • -

    Fragility fracture

  • -

    Radiographic osteopenia or vertebral compression fracture

  • -

    Height loss (≥ 4 cm without record or ≥ 2 cm with a record)

  • -

    Taking medications associated with bone loss (glucocorticoids, aromatase inhibitors, or androgen deprivation therapy)

  • -

    BMI < 20 kg/m2

  • -

    A history of parental hip fracture

Before starting osteoporosis drug and 1–2 years after treatment